ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 404 filers reported holding ENCOMPASS HEALTH CORP in Q1 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $658 | -3.9% | 9,791 | -3.3% | 0.00% | 0.0% |
| Q2 2023 | $685 | +34.8% | 10,122 | +7.7% | 0.00% | 0.0% |
| Q1 2023 | $508 | +81.4% | 9,396 | +100.3% | 0.00% | 0.0% |
| Q4 2022 | $280 | -99.9% | 4,692 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $204,000 | -31.1% | 4,518 | -14.5% | 0.00% | 0.0% |
| Q2 2022 | $296,000 | -19.3% | 5,285 | +2.4% | 0.00% | 0.0% |
| Q1 2022 | $367,000 | +28.3% | 5,161 | +17.7% | 0.00% | 0.0% |
| Q4 2021 | $286,000 | -1.4% | 4,385 | +13.3% | 0.00% | 0.0% |
| Q3 2021 | $290,000 | -7.3% | 3,870 | -3.7% | 0.00% | 0.0% |
| Q2 2021 | $313,000 | -12.1% | 4,017 | -7.7% | 0.00% | 0.0% |
| Q1 2021 | $356,000 | -3.0% | 4,350 | -2.2% | 0.00% | 0.0% |
| Q4 2020 | $367,000 | +29.7% | 4,449 | +2.0% | 0.00% | 0.0% |
| Q3 2020 | $283,000 | +18.9% | 4,361 | +13.3% | 0.00% | 0.0% |
| Q2 2020 | $238,000 | +11.7% | 3,849 | +15.5% | 0.00% | 0.0% |
| Q1 2020 | $213,000 | -16.5% | 3,333 | -9.7% | 0.00% | 0.0% |
| Q4 2019 | $255,000 | – | 3,690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BARINGTON CAPITAL GROUP, L.P. | 76,809 | $4,155,367 | 5.68% |
| Paradice Investment Management LLC | 850,583 | $46,016,540 | 3.50% |
| BERNZOTT CAPITAL ADVISORS | 273,702 | $14,807,278 | 3.06% |
| Orchard Capital Management, LLC | 135,466 | $7,328,711 | 2.45% |
| Advantage Alpha Capital Partners LP | 202,232 | $10,940,751 | 2.28% |
| REINHART PARTNERS, LLC. | 746,588 | $40,390,419 | 2.19% |
| Magnetar Financial LLC | 1,917,030 | $103,711,323 | 2.02% |
| Leeward Investments, LLC - MA | 700,894 | $37,918,365 | 1.73% |
| HEARTLAND ADVISORS INC | 505,204 | $27,331,536 | 1.69% |
| Copeland Capital Management, LLC | 1,226,985 | $66,380 | 1.56% |